Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

• DOI: 10.1093/europace/euae070
• Publication Date: 2024-04-09T12:20:48Z
• Authors: Dominik Linz; Jason G Andrade; Elena Arbelo; Giuseppe Boriani; Guenter Breithardt; A John Camm; Valeria Caso; Jens Cosedis Nielsen; Mirko De Melis; Tom De Potter; Wolfgang Dichtl; Søren Zoega Diede...; Dobromir Dobrev; Nicolas Doll; David Duncker; Elke Dworatzek; Lars Eckardt; Christoph Eisert; Larissa Fabritz; Michal Farkowski; David Filgueiras-...; Andreas Goette; Eduard Guasch; Guido Hack; Stéphane Hatem; Karl Georg Haeusler; Jeff S Healey; Hein Heidbuechel; Ziad Hijazi; Lucas H Hofmeister; Leif Hove-Madsen; Thomas Huebner; Stefan Kääb; Dipak Kotecha; Katarzyna Malaczy...; José Luis Merino; Andreas Metzner; Lluís Mont; Ghulam Andre Ng; Michael Oeff; Abdul Shokor Parwani; Helmut Puererfellner; Ursula Ravens; Michiel Rienstra; Prashanthan Sanders; Daniel Scherr; Renate Schnabel; Ulrich Schotten; Christian Sohns; Gerhard Steinbeck; Daniel Steven; Tobias Toennis; Stylianos Tzeis; Isabelle C van Ge...; Roderick H van Le...; Kevin Vernooy; Manish Wadhwa; Reza Wakili; Stephan Willems; Henning Witt; Stef Zeemering; Paulus Kirchhof
• Keywords: Stroke; Heart Rhythm; Concomitant

Abstract Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated risk AF-related complications. The aim this document to summarize key outcomes 9th AFNET/EHRA Consensus Conference Atrial Fibrillation NETwork (AFNET) European Heart Rhythm Association (EHRA). Methods results Eighty-three international experts met Münster for 2 days September 2023. Key findings are as follows: (i) Active should be part default initial treatment all suitable AF. (ii) Patients device-detected AF have stroke. Anticoagulation prevents some strokes also increases major but non-lethal bleeding. (iii) More research needed improve stroke prediction AF, especially those burden. Biomolecules, genetics, imaging can this. (iv) presence trigger systematic workup comprehensive concomitant cardiovascular conditions. (v) Machine learning algorithms been used detection or likely development Cooperation between clinicians scientists leverage potential science applications Conclusions lower other events than high Combining control, anticoagulation, rate therapy conditions lives